U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 116 results

Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2009

Class (Stereo):
CHEMICAL (ACHIRAL)



Dronedarone is an antiarrhythmic that is FDA approved for the treatment of atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (AF). Dronedarone is multichannel blocker. Common adverse reacti...
Status:
US Approved Rx (2022)
First approved in 2006

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Ranolazine is a metabolic modulator developed by Syntex (Roche) and sold under the trade name Ranexa by Gilead Sciences. Ranexa has antianginal and anti-ischemic effects that do not depend upon reductions in heart rate or blood pressure. The mechanis...
Status:
US Approved Rx (2016)
First approved in 1999

Class (Stereo):
CHEMICAL (ACHIRAL)



Dofetilide is an antiarrhythmic drug with Class III (cardiac action potential duration prolonging) properties and is indicated for the maintenance of normal sinus rhythm. Dofetilide increases the monophasic action potential duration in a predictable,...
Status:
US Approved Rx (2023)
First approved in 1996

Class (Stereo):
CHEMICAL (RACEMIC)



Midodrine is a prodrug, i.e., the therapeutic effect of orally administered midodrine is due to the major metabolite desglymidodrine formed by deglycination of midodrine. Desglymidodrine diffuses poorly across the blood-brain barrier, and is therefor...
Status:
US Approved Rx (2024)
First approved in 1995

Class (Stereo):
CHEMICAL (RACEMIC)



Ibutilide is a 'pure' class III antiarrhythmic drug, used intravenously against atrial flutter and fibrillation. At a cellular level it exerts two main actions: induction of a persistent Na+ current sensitive to dihydropyridine Ca2+ channel blockers ...
Status:
US Approved Rx (2004)
First approved in 1989

Class (Stereo):
CHEMICAL (RACEMIC)



Propafenone (brand name Rythmol SR or Rytmonorm) is a class 1C anti-arrhythmic medication, which treats illnesses associated with rapid heartbeats such as atrial and ventricular arrhythmias. The electrophysiological effect of propafenone manifests it...
Status:
US Approved Rx (2002)
First approved in 1987

Class (Stereo):
CHEMICAL (ACHIRAL)



Milrinone, a synthetic dimethylxanthine derivative structurally related to theophylline and caffeine, is used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic n...
Status:
US Approved Rx (2003)
First approved in 1985

Class (Stereo):
CHEMICAL (RACEMIC)



Flecainide is a potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial arrhythmias and tachycardias. Flecainide has local anesthetic activity and belongs to the membrane stabilizing (Class 1) group of antiarrhythmic agents;...
Status:
US Approved Rx (2024)
First approved in 1985

Class (Stereo):
CHEMICAL (ACHIRAL)



Amiodarone is an antiarrhythmic with mainly class III properties, but it possesses electrophysiologic characteristics of all four Vaughan Williams classes. Like class I drugs, amiodarone blocks sodium channels at rapid pacing frequencies, and like cl...